Evidence map›Paper›PMID 39822435›Full record

ArticleCureus2024

Efficacy of Bilastine, Dextromethorphan, and Phenylephrine Syrup in Patients With Dry Cough: A Phase 3 Randomised Trial.

Rahul Kodgule, Pankaj Magar, Sachin K Shivnitwar, Wen Wu, Amol Pendse, Sheldon Creado, Saiprasad Patil, Hanmant Barkate, Monika Tandon

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rahul KodguleResearch and Development, Glenmark Pharmaceuticals Limited, Mumbai, IND.
Pankaj MagarPulmonology, Pulse Multispecialty Hospital, Pune, IND.
Sachin K ShivnitwarGeneral Medicine, Lifepoint Multispecialty Hospital, Pune, IND.
Wen WuResearch and Development, Glenmark Pharmaceuticals Limited, Mumbai, IND.
Amol PendseResearch and Development, Glenmark Pharmaceuticals Limited, Mumbai, IND.
Sheldon CreadoGlobal Medical Affairs, Glenmark Pharmaceuticals Limited, Mumbai, IND.
Saiprasad PatilGlobal Medial Affairs, Glenmark Pharmaceuticals Limited, Mumbai, IND.
Hanmant BarkateGlobal Medial Affairs, Glenmark Pharmaceuticals Limited, Mumbai, IND.
Monika TandonResearch and Development, Glenmark Pharmaceuticals Limited, Mumbai, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Cough in common cold is often associated with rhinorrhoea and nasal congestion, requiring treatment with a cough suppressant, decongestant, and antihistamine. Bilastine is a non-sedating antihistamine, a preferred option over sedating antihistamines. A combination of bilastine, dextromethorphan, and phenylephrine is expected to provide non-sedating treatment for cough associated with a common cold or allergy. Methods In this open-label, randomized, active-controlled, multicentre, clinical trial, adult and adolescent subjects with acute dry cough received bilastine 6.6 mg/dextromethorphan 20 mg/phenylephrine 10 mg syrup (BDP) thrice daily or Alex

Indexed as

allergybilastinecommon coldcoughdextromethorphanphenylephrine

Identifiers

PMID39822435
PMCPMC11735601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.